PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-27.63%
Negative revenue growth while JHX stands at 21.81%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
23.14%
Gross profit growth similar to JHX's 24.08%. Walter Schloss would assume both firms track common industry trends.
144.19%
EBIT growth above 1.5x JHX's 67.53%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
144.19%
Operating income growth above 1.5x JHX's 67.53%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-55.08%
Negative net income growth while JHX stands at 13.44%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
131.86%
EPS growth above 1.5x JHX's 27.19%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
132.14%
Diluted EPS growth above 1.5x JHX's 31.36%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
258.50%
10Y revenue/share CAGR above 1.5x JHX's 36.58%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
71.52%
5Y revenue/share CAGR above 1.5x JHX's 36.58%. David Dodd would look for consistent product or market expansions fueling outperformance.
95.20%
3Y revenue/share CAGR above 1.5x JHX's 36.58%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
159.14%
Below 50% of JHX's 3756.91%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
126.75%
Below 50% of JHX's 3756.91%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
211.15%
Below 50% of JHX's 3756.91%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
SG&A growth well above JHX's 3.67%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.